AU2003251513A8 - Rsk inhibitors and therapeutic uses thereof - Google Patents

Rsk inhibitors and therapeutic uses thereof

Info

Publication number
AU2003251513A8
AU2003251513A8 AU2003251513A AU2003251513A AU2003251513A8 AU 2003251513 A8 AU2003251513 A8 AU 2003251513A8 AU 2003251513 A AU2003251513 A AU 2003251513A AU 2003251513 A AU2003251513 A AU 2003251513A AU 2003251513 A8 AU2003251513 A8 AU 2003251513A8
Authority
AU
Australia
Prior art keywords
therapeutic uses
rsk inhibitors
rsk
inhibitors
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003251513A
Other versions
AU2003251513A1 (en
Inventor
Yaming Xu
Deborah A Lannigan-Macara
Celeste E Poteet-Smith
David L Brautigan
Sidney M Hecht
Jeffrey A Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Virginia UVA
University of Virginia Patent Foundation
Original Assignee
University of Virginia UVA
University of Virginia Patent Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Virginia UVA, University of Virginia Patent Foundation filed Critical University of Virginia UVA
Publication of AU2003251513A8 publication Critical patent/AU2003251513A8/en
Publication of AU2003251513A1 publication Critical patent/AU2003251513A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
AU2003251513A 2002-06-12 2003-06-12 Rsk inhibitors and therapeutic uses thereof Abandoned AU2003251513A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38800602P 2002-06-12 2002-06-12
US60/388,006 2002-06-12
US44955303P 2003-02-24 2003-02-24
US60/449,553 2003-02-24
PCT/US2003/018734 WO2003105766A2 (en) 2002-06-12 2003-06-12 Rsk inhibitors and therapeutic uses thereof

Publications (2)

Publication Number Publication Date
AU2003251513A8 true AU2003251513A8 (en) 2003-12-31
AU2003251513A1 AU2003251513A1 (en) 2003-12-31

Family

ID=29739979

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003251513A Abandoned AU2003251513A1 (en) 2002-06-12 2003-06-12 Rsk inhibitors and therapeutic uses thereof

Country Status (4)

Country Link
EP (1) EP1539781A4 (en)
AU (1) AU2003251513A1 (en)
CA (1) CA2488864A1 (en)
WO (1) WO2003105766A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920393D0 (en) 1999-08-27 1999-11-03 Medix Scient Uk Limited Plant extract mixtures and their uses
KR100590818B1 (en) 2004-10-11 2006-06-19 재단법인서울대학교산학협력재단 The use of direct activation by organic agents of p90 ribosomal S6 kinase 1 RSK1 for prevention and treatment of diabetes, obesity and metabolic syndrome
CA2594542C (en) 2005-01-10 2014-03-25 University Of Virginia Patent Foundation Synthesis of inhibitors of p90rsk
JPWO2006132401A1 (en) * 2005-06-07 2009-01-08 萬有製薬株式会社 Method for evaluating compounds using RSK1
GB0512206D0 (en) 2005-06-15 2005-07-27 Biosynth As Synthesis
US7659313B2 (en) * 2007-09-13 2010-02-09 Gateway Health Alliances, Inc. Methods and related compositions using specific indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals
GB0718870D0 (en) * 2007-09-27 2007-11-07 Univ Dundee Modulation of RSK
US9040673B2 (en) 2009-08-14 2015-05-26 University Of Virginia Patent Foundation Synthesis and identification of novel RSK-specific inhibitors
CA2913583C (en) * 2012-06-04 2019-08-06 Phoenix Molecular Diagnostics Ltd. Methods of inhibiting rsk for treatment of breast cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4683700A (en) * 1999-04-30 2000-11-17 Beth Israel Deaconess Medical Center Decreasing adipose mass by altering rsk2 activity

Also Published As

Publication number Publication date
WO2003105766A3 (en) 2004-03-11
WO2003105766A2 (en) 2003-12-24
EP1539781A2 (en) 2005-06-15
CA2488864A1 (en) 2003-12-24
EP1539781A4 (en) 2009-12-02
AU2003251513A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
EP1539941A4 (en) Adzymes and uses thereof
PL374598A1 (en) Caspase inhibitors and uses thereof
ZA200509700B (en) Caspase inhibitors and uses thereof
EP1511488A4 (en) Human adam-10 inhibitors
EP1682136A4 (en) Therapeutic compounds and uses thereof
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
GB0220214D0 (en) Compounds and their use
AU2003251513A8 (en) Rsk inhibitors and therapeutic uses thereof
GB0207410D0 (en) Compounds and their therapeutic use
IL165112A0 (en) Variant integrinpolypeptides and thereof
AU2003231827A8 (en) Pseudo-tissues and uses thereof
GB0227906D0 (en) Compounds and their use
AU2003302173A8 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
EP1569928A4 (en) Therapeutic compounds and methods
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
AU2003267790A8 (en) Lipase inhibitors and uses thereof
GB0220776D0 (en) FOXP2 and uses thereof
GB0230134D0 (en) Compounds and their use
GB0205826D0 (en) Therapeutic compositions and methods
AU2003216442A8 (en) Enkurin and uses thereof
EP1499338A4 (en) 7-hydroxy-16alpha-fluoro-5-androsten-17-ones and 7-hydroxy-16alpha-fluoro-5-androstan-17-ones and derivatives thereof
GB0218031D0 (en) Compounds and their use
ZA200500776B (en) Caspase inhibitors and uses thereof
GB0215773D0 (en) Compunds and their therapeutic use
GB0213498D0 (en) Deoxyhypusine-synthase inhibitors pharmaceuticals comprising said inhibitors and uses thereof